Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39024

DNAAF2 Knockout HGC-27 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Stomach

  • Disease:

    Carcinoma

Delineate the DNAAF2 Knockout HGC-27 Polyclonal Cells, a CRISPR/Cas9-edited polyclonal knockout cell population in the HGC-27 gastric carcinoma line with disrupted DNAAF2, a dynein axonemal assembly factor essential for ciliary motility. This loss-of-function model operates downstream of FOXJ1 and RFX transcription factors and interacts with DNAAF1, DNAH5, and DNAH11 to assemble dynein arms. Applications include primary ciliary dyskinesia research, cilia-mediated gastric cancer motility assays, and ciliary function studies. Supported readouts encompass immunofluorescence for ciliary markers, high-speed video microscopy for beat frequency, western blotting for dynein components, and migration/invasion assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HGC-27

    Sex of Donor

    Unknown

    Age

    Unknown

    Derived From Site

    Metastatic; Lymph node

    Gene Name

    DNAAF2

    Gene Identifier

    NCBI Gene ID 55172

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAAF2 Knockout HGC-27 Polyclonal Cells product is a CRISPR/Cas9-edited polyclonal knockout cell population designed for loss-of-function studies of the DNAAF2 gene in the HGC-27 human gastric carcinoma cell line. DNAAF2 encodes a dynein axonemal assembly factor required for the cytoplasmic pre-assembly of axonemal dynein arms, the molecular motors driving ciliary motility. This polyclonal pool provides a heterogeneous knockout population, avoiding clonal artifacts and enabling robust functional analyses in a cancer-relevant cellular context.

The HGC-27 host cell line is an epithelial cell line derived from a metastatic lymph node of a gastric cancer patient. It is a well-characterized model for gastric carcinoma research, widely used to investigate proliferation, migration, and invasion. HGC-27 cells are capable of forming primary cilia under defined conditions, making them valuable for studying ciliary biology and its intersection with tumor progression.

DNAAF2 functions in a pre-assembly pathway regulated by the ciliogenic transcription factors FOXJ1 and RFX. In the cytoplasm, it interacts with DNAAF1 (LRRC50) to facilitate the stable assembly of dynein heavy chains, including DNAH5 and DNAH11, into functional dynein arm complexes. Other key pathway members include dynein intermediate chains DNAI1 and DNAI2. Disruption of DNAAF2 blocks outer dynein arm formation, impairing ciliary beat frequency and motility.

In the HGC-27 gastric cancer context, DNAAF2 knockout disrupts ciliary function, which can modulate cell migration and invasion??processes linked to ciliary signaling. This polyclonal model enables the study of cilia-dependent mechanisms in gastric cancer progression and serves as a tool for investigating primary ciliary dyskinesia-associated phenotypes in a non-classical cell background.

This knockout population is suited for diverse applications, including ciliary function assays, disease modeling, and gastric cancer motility studies. Relevant readouts include immunofluorescence for ciliary markers (acetylated ??-tubulin, ARL13B), high-speed video microscopy for ciliary beat frequency, western blotting for dynein components (DNAH5, DNAI1), migration/invasion transwell assays, and RT-qPCR for ciliogenesis genes. For inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)